Efficacy and safety of peginterferon alfa-2a + RBV in cHCV/HIV- vs cHCV-infected patients: interim analysis of a multicenter German cohort

by Baumgarten, A, Lutz, T, Kreckel, P, Wellmann, E, Alshuth, U, Mauss, S, Rockstroh, J
Published 2010

Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients

by Stephan, C, Jaeger, H, Carganico, A, Knecht, G, Lutz, T, Mayr, C, Mosthaf, FA, Koeppe, S, Mueller, M, Wolf, E, Tappe, A, Wellmann, E, Knechten, H
Published 2010

The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naïve and pre-treated but protease inhibitor (PI)- naïve hiv-infe...

by Knechten, H, Stephan, C, Mosthaf, FA, Jaeger, H, Carganico, A, Lutz, T, Schewe, K, Mayr, C, Wolf, E, Wellmann, E, Tappe, A
Published 2011